Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of surgery for high-risk prostate cancer.
Joniau S, Tosco L, Briganti A, Vanden Broeck T, Gontero P, Karnes RJ, Spahn M, Van Poppel H; European Multicenter Prostate Cancer Clinical and Translational research group. Joniau S, et al. Curr Opin Urol. 2013 Jul;23(4):342-8. doi: 10.1097/MOU.0b013e3283620f60. Curr Opin Urol. 2013. PMID: 23702565 Review.
Androgen receptor antagonists for prostate cancer therapy.
Helsen C, Van den Broeck T, Voet A, Prekovic S, Van Poppel H, Joniau S, Claessens F. Helsen C, et al. Among authors: van den broeck t, van poppel h. Endocr Relat Cancer. 2014 Aug;21(4):T105-18. doi: 10.1530/ERC-13-0545. Epub 2014 Mar 17. Endocr Relat Cancer. 2014. PMID: 24639562 Review.
Obesity and prostate cancer research.
Van den Broeck T, Tosco L, Prekovic S, Joniau S. Van den Broeck T, et al. Cent European J Urol. 2014;66(4):428-9. doi: 10.5173/ceju.2013.04.art8. Cent European J Urol. 2014. PMID: 24757533 Free PMC article. No abstract available.
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.
Droz JP, Aapro M, Balducci L, Boyle H, Van den Broeck T, Cathcart P, Dickinson L, Efstathiou E, Emberton M, Fitzpatrick JM, Heidenreich A, Hughes S, Joniau S, Kattan M, Mottet N, Oudard S, Payne H, Saad F, Sugihara T. Droz JP, et al. Among authors: van den broeck t. Lancet Oncol. 2014 Aug;15(9):e404-14. doi: 10.1016/S1470-2045(14)70018-X. Lancet Oncol. 2014. PMID: 25079103 Review.
Emerging mechanisms of enzalutamide resistance in prostate cancer.
Claessens F, Helsen C, Prekovic S, Van den Broeck T, Spans L, Van Poppel H, Joniau S. Claessens F, et al. Among authors: van den broeck t, van poppel h. Nat Rev Urol. 2014 Dec;11(12):712-6. doi: 10.1038/nrurol.2014.243. Epub 2014 Sep 16. Nat Rev Urol. 2014. PMID: 25224448
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.
van den Bergh RC, van Casteren NJ, van den Broeck T, Fordyce ER, Gietzmann WK, Stewart F, MacLennan S, Dabestani S, Bellmunt J, Bolla M, Briers E, Cornford P, Joniau S, Mason MD, Matveev V, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Lam TB, Mottet N. van den Bergh RC, et al. Among authors: van casteren nj, van den broeck t, van der kwast th, van der poel hg. Eur Urol. 2016 May;69(5):802-20. doi: 10.1016/j.eururo.2015.11.023. Epub 2015 Dec 12. Eur Urol. 2016. PMID: 26691493 Review.
95 results